The Bedrock of Biotech

of readers depend on GEN as a primary source of industry information

GEN is built on a foundation of editorial excellence, providing unrivaled breadth of exclusive editorial coverage and expertise that encompasses the entire bioproduct lifecycle. In 2019, a stunning new redesign and format of our core products – Magazine, Website, and eNewsletters – showcases a wealth of new original content developed to provide deeper coverage of the scientific and technological advances, tools, pioneers, and ideas that are driving the industry.

Expanded coverage in our core areas of Drug Discovery, OMICS, Bioprocessing, and Translational Medicine is now complemented by:

Editorial Leadership

John Sterling

Editor in Chief

Kevin Davies

EVP, Strategic Development

Download the 2019 Media Kit